#Merck

16 Oct 2026

Melanoma Patient Shares Experience With mRNA Vaccine Trial

A melanoma survivor speaks at the STAT Summit about the emotional journey of a clinical trial that combined a Merck–Moderna mRNA vaccine with immunotherapy.

Read more

16 Oct 2026

Merck and Moderna’s mRNA cancer vaccine delays melanoma recurrence in phase 3 trial

A large phase 3 trial of the personalized vaccine, combined with Keytruda, slowed melanoma recurrence and metastatic progression

Read more